SCHEMBL14765203

SCHEMBL14765203

COc1ccc(-c2nnc3c(C)nc4ccccc4n23)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.67
MAOB P27338 1/20 0.67
PDE2A O00408 12/20 0.67
PDE10A Q9Y233 11/20 0.67
TYMS P04818 1/20 0.53
KDM4E B2RXH2 4/20 0.53
ALDH1A1 P00352 4/20 0.53
MAPT P10636 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
NPC1 O15118 1/20 0.53
TP53 P04637 1/20 0.53
RAB9A P51151 1/20 0.53
HPGD P15428 1/20 0.53
GAA P10253 2/20 0.53
LMNA P02545 2/20 0.52
CNR2 P34972 1/20 0.52
HTT P42858 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
TSHR P16473 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14764776 0.86 TYMS (0.70) MAOAPDE2APDE10ATYMSKDM4E
SCHEMBL14765009 0.85 MAOA (0.62) MAOAMAOBPDE2APDE10ATYMS
SCHEMBL12502817 0.80 PDE2A (1.00) PDE2APDE10A
SCHEMBL14054628 0.79 PDE2A (0.68) PDE2APDE10AALDH1A1
SCHEMBL12502608 0.78 PDE2A (1.00) PDE2APDE10A
SCHEMBL14359766 0.75 PDE2A (0.58) PDE2APDE10ATYMSKDM4EALDH1A1
SCHEMBL5011775 0.74 ALDH1A1 (0.68) KDM4EALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL12503035 0.74 PDE2A (0.80) PDE2APDE10A
SCHEMBL14362008 0.74 PDE2A (0.80) PDE2APDE10A
SCHEMBL14362116 0.73 PDE2A (0.76) PDE2APDE10ATYMS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 WO claimed
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 WO disclosed
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 WO disclosed